Skip to main navigation
Optinose
  • Join Our Team
  • Contact Us
  • Company
    • Our Purpose
    • Company History
    • Leadership Team
    • Board of Directors
    • Partnership Opportunities
    • Corporate Compliance
  • Exhalation
    Delivery Systems
    • Liquid Delivery
    • Powder Delivery Device
    • Anatomy of the Nasal Passages
    • Nasal Delivery Challenges
  • Therapeutic
    Areas
  • Products
    • XHANCE®
    • ONZETRA® Xsail®
  • Research &
    Development
    • XHANCE® - Future Development
    • Partnerships
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Proxy Materials
    • Investor Resources
  • News &
    Media
  • Scientific
    Communications
    • Peer-Reviewed Journal Publications

News Releases


News Releases

Optinose Q4 2020 Earnings Conference Call
Wednesday, March 03, 2021 at 8:00 AM EST
Click here for webcast
Cowen and Company 41st Annual Health Care Conference
Thursday, March 04, 2021 at 1:30 PM EST
Click here for webcast

Keyword Search

Date Title  
03/03/21
Optinose Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
Printer Friendly Version
02/17/21
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
Printer Friendly Version
01/25/21
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Printer Friendly Version

Investors

  • News & Events
    • News Releases
    • Event Calendar
    • Presentations
  • Stock Information
  • Corporate Governance
  • SEC Filings
  • Proxy Materials
  • Investor Resources

Toolkit

  • Printer Friendly Version Print page
  • E-mail Alerts Sign up for email alerts

  • Investor Contact

    Jonathan Neely
    VP Investor Relations and Business Operations
    Email: investors@optinose.com
Contact Us
P.O. Terms & Conditions
Join Our Team
Privacy Policy
Terms of Use
Site Map
Footer Logo
©2021 Optinose. OPTINOSE-17-013a 09/2017